Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease.
Muthukumaran K, Kanwar A, Vegh C, Marginean A, Elliott A, Guilbeault N, Badour A, Sikorska M, Cohen J, Pandey S. Muthukumaran K, et al. Among authors: sikorska m. J Alzheimers Dis. 2018;61(1):221-236. doi: 10.3233/JAD-170275. J Alzheimers Dis. 2018. PMID: 29154270
Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10.
Somayajulu-Niţu M, Sandhu JK, Cohen J, Sikorska M, Sridhar TS, Matei A, Borowy-Borowski H, Pandey S. Somayajulu-Niţu M, et al. Among authors: sikorska m. BMC Neurosci. 2009 Jul 27;10:88. doi: 10.1186/1471-2202-10-88. BMC Neurosci. 2009. PMID: 19635141 Free PMC article.
Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson's disease.
Muthukumaran K, Leahy S, Harrison K, Sikorska M, Sandhu JK, Cohen J, Keshan C, Lopatin D, Miller H, Borowy-Borowski H, Lanthier P, Weinstock S, Pandey S. Muthukumaran K, et al. Among authors: sikorska m. BMC Neurosci. 2014 Jan 31;15:21. doi: 10.1186/1471-2202-15-21. BMC Neurosci. 2014. PMID: 24483602 Free PMC article.
Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.
Sikorska M, Lanthier P, Miller H, Beyers M, Sodja C, Zurakowski B, Gangaraju S, Pandey S, Sandhu JK. Sikorska M, et al. Neurobiol Aging. 2014 Oct;35(10):2329-46. doi: 10.1016/j.neurobiolaging.2014.03.032. Epub 2014 Apr 2. Neurobiol Aging. 2014. PMID: 24775711 Free PMC article.
Correction to: Orally delivered water soluble coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson's disease.
Muthukumaran K, Leahy S, Harrison K, Sikorska M, Sandhu JK, Cohen J, Keshan C, Lopatin D, Miller H, Borowy-Borowski H, Lanthier P, Weinstock S, Pandey S. Muthukumaran K, et al. Among authors: sikorska m. BMC Neurosci. 2021 Dec 20;22(1):79. doi: 10.1186/s12868-021-00684-7. BMC Neurosci. 2021. PMID: 34930123 Free PMC article. No abstract available.
193 results